Med-Mastodon

Futurist Jim Carroll**Megatrend #12** - Personalized, Precision Medicine: "Tomorrow's cure lies not in a universal pill, but within our own genetic code." - Futurist Jim Carroll---(Futurist Jim Carroll is writing a series on 30 Megatrends, which he first outlined in his book Dancing in the Rain: How Bold Leaders Grow Stronger in Stormy Times. The trends were shared in the book as a way of demonstrating that, despite any period of economic volatility, there is always long-term opportunity to be found. The book is now in print - learn more at dancing.jimcarroll.com)---The one-size-fits-all era in medicine is ending. Treatments, nutrition, and wellness approaches tailored to individual genetic profiles are becoming the standard, not the exception. As with every post in this series, there's a PDF here that goes into more depth on this trend.There's a little bit of duplication with some of the material covered in previous megatrends with this one, but it's important ot note that this trend is powerful enough on its own to deserve its own post.What's it all about? We are combining what we might call 'next-generation genomic sequencing', AI, and CRISPR gene editing, to come up with a new health paradigm that involves 'fixing people before they are sick rather than after.' Why these 3 trends? The cost for genomic sequencing is collapsing, AI is accelerating the ability to do so, and gene editing allows us to correct the genetic causes of disease at the source.Before going further, it's important to define the revolution by understanding two key terms.The first is Personalized Medicine, which uses an individual's unique genomic, environmental, and lifestyle information to guide decisions for prevention, diagnosis, and treatment of disease. It's based on the idea that because no two individuals are the same, they should not receive the same healthcare.The second term is Precision Medicine. While often used interchangeably, it more accurately describes the strategy of stratifying individuals into small populations based on shared characteristics. It focuses on identifying which healthcare and pharmaceutical approaches will be most effective for those small, specific groups of people, rather than creating unique treatments for each individual.While its potential is immense, the transition to personalized medicine is not merely a technological upgrade but a disruptive force that challenges the foundational structures of healthcare delivery, research, and regulation.Even so, over the long term, it's one of the biggest megatrend opportunities of our time.**<a href="https://mastodon.futurist.info/tags/Personalized" class="mention hashtag" rel="nofollow noopener" target="_blank">#Personalized</a>** **<a href="https://mastodon.futurist.info/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a>** **<a href="https://mastodon.futurist.info/tags/Genomics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genomics</a>** **<a href="https://mastodon.futurist.info/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>** **<a href="https://mastodon.futurist.info/tags/AI" class="mention hashtag" rel="nofollow noopener" target="_blank">#AI</a>** **<a href="https://mastodon.futurist.info/tags/Precision" class="mention hashtag" rel="nofollow noopener" target="_blank">#Precision</a>** **<a href="https://mastodon.futurist.info/tags/Healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#Healthcare</a>** **<a href="https://mastodon.futurist.info/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a>** **<a href="https://mastodon.futurist.info/tags/Innovation" class="mention hashtag" rel="nofollow noopener" target="_blank">#Innovation</a>** **<a href="https://mastodon.futurist.info/tags/Future" class="mention hashtag" rel="nofollow noopener" target="_blank">#Future</a>**Original post: <a href="https://jimcarroll.com/2025/07/decoding-tomorrow-30-megatrends-12-personalized-medicine-tomorrows-cure-lies-not-in-a-universal-pill-but-within-our-own-genetic-code/" rel="nofollow noopener" translate="no" target="_blank">https://jimcarroll.com/2025/07/decoding-tomorrow-30-megatrends-12-personalized-medicine-tomorrows-cure-lies-not-in-a-universal-pill-but-within-our-own-genetic-code/</a>

prabirkc<a href="https://mastodon.social/tags/Gene" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gene</a> Editing - Do listen to Dr Krithika <a href="https://www.youtube.com/live/N8gtxshfxhI?si=JJtU7iHN-QurHJy6" rel="nofollow noopener" translate="no" target="_blank">https://www.youtube.com/live/N8gtxshfxhI?si=JJtU7iHN-QurHJy6</a> <a href="https://mastodon.social/tags/Biology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biology</a> <a href="https://mastodon.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://mastodon.social/tags/Rice" class="mention hashtag" rel="nofollow noopener" target="_blank">#Rice</a> <a href="https://mastodon.social/tags/India" class="mention hashtag" rel="nofollow noopener" target="_blank">#India</a> <a href="https://mastodon.social/tags/Emvironment" class="mention hashtag" rel="nofollow noopener" target="_blank">#Emvironment</a> <a href="https://mastodon.social/tags/Food" class="mention hashtag" rel="nofollow noopener" target="_blank">#Food</a> #<a href="https://mastodon.social/tags/GM" class="mention hashtag" rel="nofollow noopener" target="_blank">#GM</a>

JIPBThe HI-Edit system combines haploid induction and <a href="https://mstdn.science/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>/Cas-based <a href="https://mstdn.science/tags/genome" class="mention hashtag" rel="nofollow noopener" target="_blank">#genome</a> editing to provide a promising way to design <a href="https://mstdn.science/tags/crops" class="mention hashtag" rel="nofollow noopener" target="_blank">#crops</a> with desired traits in a rapid, precise and transgene-free manner. Read on...for <a href="https://mstdn.science/tags/free" class="mention hashtag" rel="nofollow noopener" target="_blank">#free</a>!⬇️🔓 <a href="https://doi.org/10.1111/jipb.13943" rel="nofollow noopener" translate="no" target="_blank">https://doi.org/10.1111/jipb.13943</a> @wileyplantsci <a href="https://mstdn.science/tags/PlantSci" class="mention hashtag" rel="nofollow noopener" target="_blank">#PlantSci</a> <a href="https://mstdn.science/tags/JIPB" class="mention hashtag" rel="nofollow noopener" target="_blank">#JIPB</a> <a href="https://mstdn.science/tags/botany" class="mention hashtag" rel="nofollow noopener" target="_blank">#botany</a> <a href="https://mstdn.science/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#OpenAccess</a>

Bianor Biotech SL¿Qué piensas de la edición génica en humanos? La aparición de herramientas como CRISPR-Cas9 ofrecen múltiples posibilidades, pero también plantean dilemas éticos, especialmente cuando se trata de alterar la línea germinal. <a href="https://www.sciencedirect.com/science/article/abs/pii/S0015028225002535" rel="nofollow noopener" translate="no" target="_blank">https://www.sciencedirect.com/science/article/abs/pii/S0015028225002535</a> <a href="https://fediscience.org/tags/bianorbiotech" class="mention hashtag" rel="nofollow noopener" target="_blank">#bianorbiotech</a> <a href="https://fediscience.org/tags/Germline" class="mention hashtag" rel="nofollow noopener" target="_blank">#Germline</a> <a href="https://fediscience.org/tags/GeneCorrection" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneCorrection</a> <a href="https://fediscience.org/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://fediscience.org/tags/ethics" class="mention hashtag" rel="nofollow noopener" target="_blank">#ethics</a>

Lluis MontoliuTengo una noticia importante que contaros. He acordado con <a href="https://bird.makeup/users/pinolialibros" class="u-url mention" rel="nofollow noopener" target="_blank">@pinolialibros</a> reeditar mis cuatro libros publicados con Next Door. El primero será "<a href="https://mastodon.world/tags/EditandoGenes" class="mention hashtag" rel="nofollow noopener" target="_blank">#EditandoGenes</a> : recorta, pega y colorea. Las maravillosas herramientas <a href="https://mastodon.world/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>" cuya reedición está prevista para septiembre. ¡Gracias!

US<a href="https://www.europesays.com/us/14780/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/us/14780/</a> [Latest] Global Cell and Gene Therapy Market Size/Share <a href="https://pubeurope.com/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a> <a href="https://pubeurope.com/tags/Cancer" class="mention hashtag" rel="nofollow noopener" target="_blank">#Cancer</a> <a href="https://pubeurope.com/tags/Cardiovascular" class="mention hashtag" rel="nofollow noopener" target="_blank">#Cardiovascular</a> <a href="https://pubeurope.com/tags/Cell" class="mention hashtag" rel="nofollow noopener" target="_blank">#Cell</a> <a href="https://pubeurope.com/tags/CGT" class="mention hashtag" rel="nofollow noopener" target="_blank">#CGT</a> <a href="https://pubeurope.com/tags/CMI" class="mention hashtag" rel="nofollow noopener" target="_blank">#CMI</a> <a href="https://pubeurope.com/tags/CMIMARKETRESEARCHPRIVATELIMITED" class="mention hashtag" rel="nofollow noopener" target="_blank">#CMIMARKETRESEARCHPRIVATELIMITED</a> <a href="https://pubeurope.com/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://pubeurope.com/tags/Gene" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gene</a> <a href="https://pubeurope.com/tags/genetic" class="mention hashtag" rel="nofollow noopener" target="_blank">#genetic</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/hematology" class="mention hashtag" rel="nofollow noopener" target="_blank">#hematology</a> <a href="https://pubeurope.com/tags/hospitals" class="mention hashtag" rel="nofollow noopener" target="_blank">#hospitals</a> <a href="https://pubeurope.com/tags/Neurological" class="mention hashtag" rel="nofollow noopener" target="_blank">#Neurological</a> <a href="https://pubeurope.com/tags/Oncology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Oncology</a> <a href="https://pubeurope.com/tags/ophthalmology" class="mention hashtag" rel="nofollow noopener" target="_blank">#ophthalmology</a> <a href="https://pubeurope.com/tags/Rare" class="mention hashtag" rel="nofollow noopener" target="_blank">#Rare</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/Therapy" class="mention hashtag" rel="nofollow noopener" target="_blank">#Therapy</a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStates</a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedStates</a> <a href="https://pubeurope.com/tags/US" class="mention hashtag" rel="nofollow noopener" target="_blank">#US</a> <a href="https://pubeurope.com/tags/Vivo" class="mention hashtag" rel="nofollow noopener" target="_blank">#Vivo</a>

Lluis MontoliuEn este vídeo del programa <a href="https://mastodon.world/tags/ciceron" class="mention hashtag" rel="nofollow noopener" target="_blank">#ciceron</a> del <a href="https://mastodon.world/tags/csic" class="mention hashtag" rel="nofollow noopener" target="_blank">#csic</a> explico la participación de nuestro laboratorio del CNB Consorcio CIBER <a href="https://mastodon.world/tags/CIBERER" class="mention hashtag" rel="nofollow noopener" target="_blank">#CIBERER</a> y sobre qué investigamos, usando modelos animales (ratones avatar) <a href="https://mastodon.world/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> en la red de <a href="https://mastodon.world/tags/enfermedadesraras" class="mention hashtag" rel="nofollow noopener" target="_blank">#enfermedadesraras</a> <a href="https://youtu.be/_jTN-XQe_BU" rel="nofollow noopener" translate="no" target="_blank">https://youtu.be/_jTN-XQe_BU</a>

Hacker NewsA Visual Guide to Genome Editors<a href="https://www.asimov.press/p/a-visual-guide-to-genome-editors" rel="nofollow noopener" translate="no" target="_blank">https://www.asimov.press/p/a-visual-guide-to-genome-editors</a><a href="https://mastodon.social/tags/HackerNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#HackerNews</a> <a href="https://mastodon.social/tags/GenomeEditing" class="mention hashtag" rel="nofollow noopener" target="_blank">#GenomeEditing</a> <a href="https://mastodon.social/tags/VisualGuide" class="mention hashtag" rel="nofollow noopener" target="_blank">#VisualGuide</a> <a href="https://mastodon.social/tags/Biotechnology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biotechnology</a> <a href="https://mastodon.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://mastodon.social/tags/ScienceEducation" class="mention hashtag" rel="nofollow noopener" target="_blank">#ScienceEducation</a> <a href="https://mastodon.social/tags/Genomics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genomics</a>

Axel Gutmann<a href="https://social.bund.de/@strahlenschutz" class="u-url mention" rel="nofollow noopener" target="_blank">@strahlenschutz</a> ... und dieses reine Zufallsverfahren gilt dann nicht als riskante <a href="https://sueden.social/tags/Gentechnik" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gentechnik</a>, präzise Verfahren mit planbaren Ergebnissen wie <a href="https://sueden.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>/Cas9 aber schon ...

Lluis MontoliuHoy estaré en <a href="https://mastodon.world/tags/CaixaForum" class="mention hashtag" rel="nofollow noopener" target="_blank">#CaixaForum</a> Madrid conduciendo el diálogo sobre las aplicaciones de las herramientas <a href="https://mastodon.world/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> de edición genética en agricultura y biomedicina junto a varios colegas a propuesta de la <a href="https://mastodon.world/tags/ONAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#ONAC</a> para mejorar la toma de decisiones en ministerios, MAPA y Sanidad <a href="https://www.onac.gob.es/novedades/eventos/paginas/dialogos-ciencia-politica-crispr.aspx" rel="nofollow noopener" translate="no" target="_blank">https://www.onac.gob.es/novedades/eventos/paginas/dialogos-ciencia-politica-crispr.aspx</a>

UK<a href="https://www.europesays.com/uk/180085/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/180085/</a> Autophagy boosts precision in gene editing <a href="https://pubeurope.com/tags/Autophagy" class="mention hashtag" rel="nofollow noopener" target="_blank">#Autophagy</a> <a href="https://pubeurope.com/tags/Cas9" class="mention hashtag" rel="nofollow noopener" target="_blank">#Cas9</a> <a href="https://pubeurope.com/tags/crispr" class="mention hashtag" rel="nofollow noopener" target="_blank">#crispr</a> <a href="https://pubeurope.com/tags/DNA" class="mention hashtag" rel="nofollow noopener" target="_blank">#DNA</a> <a href="https://pubeurope.com/tags/Gene" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gene</a> <a href="https://pubeurope.com/tags/Genetic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetic</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/Genome" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genome</a> <a href="https://pubeurope.com/tags/GenomeEditing" class="mention hashtag" rel="nofollow noopener" target="_blank">#GenomeEditing</a> <a href="https://pubeurope.com/tags/Homologous" class="mention hashtag" rel="nofollow noopener" target="_blank">#Homologous</a> <a href="https://pubeurope.com/tags/HomologousRecombination" class="mention hashtag" rel="nofollow noopener" target="_blank">#HomologousRecombination</a> <a href="https://pubeurope.com/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a> <a href="https://pubeurope.com/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/Technology" class="mention hashtag" rel="nofollow noopener" target="_blank">#Technology</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

Glen L CreasyA heartening story about how CRISPR is being used to develop citrus trees resistant to huanglongbing (HLB, also known as citrus greening), carried by the the Asian citrus psyllid.In 20 years, the disease reduced citrus production in Florida by more than 60%: infected trees can die in as few as 5 years.If all goes well, in 2027 resistant trees may be planted in commercial orchards.<a href="https://www.pbs.org/newshour/show/how-researchers-in-florida-are-using-gene-editing-to-protect-the-states-orange-groves" rel="nofollow noopener" translate="no" target="_blank">https://www.pbs.org/newshour/show/how-researchers-in-florida-are-using-gene-editing-to-protect-the-states-orange-groves</a><a href="https://epicure.social/tags/CitrusProduction" class="mention hashtag" rel="nofollow noopener" target="_blank">#CitrusProduction</a> <a href="https://epicure.social/tags/Florida" class="mention hashtag" rel="nofollow noopener" target="_blank">#Florida</a> <a href="https://epicure.social/tags/Oranges" class="mention hashtag" rel="nofollow noopener" target="_blank">#Oranges</a> <a href="https://epicure.social/tags/BacterialDisease" class="mention hashtag" rel="nofollow noopener" target="_blank">#BacterialDisease</a> <a href="https://epicure.social/tags/InsectVector" class="mention hashtag" rel="nofollow noopener" target="_blank">#InsectVector</a> <a href="https://epicure.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>

Cosmin SaveanuImpressive work on functional screening in human cells: <a href="https://pubmed.ncbi.nlm.nih.gov/40442371/" rel="nofollow noopener" translate="no" target="_blank">https://pubmed.ncbi.nlm.nih.gov/40442371/</a> With one of the most detailed data analysis and visualization code available: <a href="https://github.com/rasilab/nugent_2024" rel="nofollow noopener" translate="no" target="_blank">https://github.com/rasilab/nugent_2024</a>PS The use of barcoded RNA reminded me our own past work in yeast (<a href="https://pubmed.ncbi.nlm.nih.gov/24529707/" rel="nofollow noopener" translate="no" target="_blank">https://pubmed.ncbi.nlm.nih.gov/24529707/</a>)<a href="https://framapiaf.org/tags/RNA" class="mention hashtag" rel="nofollow noopener" target="_blank">#RNA</a> <a href="https://framapiaf.org/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>

MIT Technology Review DEKrypto-Milliardär Brian Armstrong ist bereit, in CRISPR-Baby-Technologie zu investieren. Es die erste große kommerzielle Investition in eines der umstrittensten Projekte der Medizin.<a href="https://social.heise.de/tags/Gentechnik" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gentechnik</a> <a href="https://social.heise.de/tags/Genetik" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetik</a> <a href="https://social.heise.de/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://t3n.de/news/designer-babys-durch-crispr-coinbase-ceo-will-in-gentechnik-investieren-1691659/" rel="nofollow noopener" translate="no" target="_blank">https://t3n.de/news/designer-babys-durch-crispr-coinbase-ceo-will-in-gentechnik-investieren-1691659/</a>

Marcel SIneM(S)USGentechnik-Debatte: Landwirte kämpfen mit Klimaschäden auf Feldern | heise online <a href="https://www.heise.de/news/Gentechnik-Debatte-Landwirte-kaempfen-mit-Klimaschaeden-auf-Feldern-10435354.html" rel="nofollow noopener" translate="no" target="_blank">https://www.heise.de/news/Gentechnik-Debatte-Landwirte-kaempfen-mit-Klimaschaeden-auf-Feldern-10435354.html</a> <a href="https://social.tchncs.de/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://social.tchncs.de/tags/DNA" class="mention hashtag" rel="nofollow noopener" target="_blank">#DNA</a> <a href="https://social.tchncs.de/tags/Forschung" class="mention hashtag" rel="nofollow noopener" target="_blank">#Forschung</a> <a href="https://social.tchncs.de/tags/research" class="mention hashtag" rel="nofollow noopener" target="_blank">#research</a> <a href="https://social.tchncs.de/tags/Wissenschaft" class="mention hashtag" rel="nofollow noopener" target="_blank">#Wissenschaft</a> <a href="https://social.tchncs.de/tags/science" class="mention hashtag" rel="nofollow noopener" target="_blank">#science</a>

Levka<a href="https://kolektiva.social/tags/cancer" class="mention hashtag" rel="nofollow noopener" target="_blank">#cancer</a> <a href="https://kolektiva.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>December 2023"Researchers are closing in on ways to produce CAR T cells in the body, raising hopes that the notoriously expensive and bespoke cancer therapies might one day become more accessible.In CAR-T treatment, immune cells called T cells are removed from the person receiving treatment, engineered to target cancer cells and reintroduced to their body. The process has yielded dramatic recoveries from advanced forms of some blood cancers, but its high price and technical difficulty have placed it out of reach for many people.Results presented at the American Society of Hematology annual meeting in San Diego, California on 11 December suggest that people undergoing treatment might eventually just get an injection of a virus that infects T cells. The virus would then insert the genes needed to guide the T cells to tumour cells."<a href="https://archive.ph/mVBNn" rel="nofollow noopener" translate="no" target="_blank">https://archive.ph/mVBNn</a>

Levka<a href="https://kolektiva.social/tags/cancer" class="mention hashtag" rel="nofollow noopener" target="_blank">#cancer</a> <a href="https://kolektiva.social/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a>June 2025:"Some biotechnology companies have an answer: alter T cells inside the body instead. Treatments that deliver a gene for the CAR protein to cells in the blood could be mass produced and available on demand — theoretically, at a much lower price than current CAR-T therapies. A single dose of commercial CAR-T therapy costs around $500,000. A vial of in vivo treatment might cost an order of magnitude less.The idea has some high-profile proponents. The founders of Capstan Therapeutics, a company in San Diego, California, that is focused exclusively on in vivo cell therapies, include CAR-T pioneers Levine and Carl June, as well as Drew Weissman, who won a Nobel prize for his work on messenger RNA vaccines. CRISPR–Cas9 pioneer and Nobel prizewinner Jennifer Doudna has co-founded a separate company, Azalea Therapeutics in Berkeley, California, that is developing in vivo CAR T. And big pharma is taking notice. In March, the biopharmaceutical firm AstraZeneca agreed to pay up to $1 billion for the Belgium-based in vivo CAR-T company EsoBiotec, which launched its first human trial of an in vivo CAR-T therapy in January."<a href="https://www.nature.com/articles/d41586-025-01570-6" rel="nofollow noopener" translate="no" target="_blank">https://www.nature.com/articles/d41586-025-01570-6</a>

heise onlineGentechnik-Debatte: Landwirte kämpfen mit Klimaschäden auf FeldernAngesichts der Klimakrise wächst bei einigen Landwirten die Hoffnung auf gentechnisch veränderte Pflanzen – doch Kritiker warnen vor Risiken.<a href="https://www.heise.de/news/Gentechnik-Debatte-Landwirte-kaempfen-mit-Klimaschaeden-auf-Feldern-10435354.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon" rel="nofollow noopener" translate="no" target="_blank">https://www.heise.de/news/Gentechnik-Debatte-Landwirte-kaempfen-mit-Klimaschaeden-auf-Feldern-10435354.html?wt_mc=sm.red.ho.mastodon.mastodon.md_beitraege.md_beitraege&utm_source=mastodon</a><a href="https://social.heise.de/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://social.heise.de/tags/Genetik" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetik</a> <a href="https://social.heise.de/tags/Gentechnik" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gentechnik</a> <a href="https://social.heise.de/tags/Landwirtschaft" class="mention hashtag" rel="nofollow noopener" target="_blank">#Landwirtschaft</a> <a href="https://social.heise.de/tags/Wissenschaft" class="mention hashtag" rel="nofollow noopener" target="_blank">#Wissenschaft</a> <a href="https://social.heise.de/tags/news" class="mention hashtag" rel="nofollow noopener" target="_blank">#news</a>

Moreno Colaiacovo 🇪🇺"A selected encyclopedia of major gene-editing systems, together with illustrated diagrams."<a href="https://mastodon.uno/tags/crispr" class="mention hashtag" rel="nofollow noopener" target="_blank">#crispr</a> <a href="https://mastodon.uno/tags/genomeediting" class="mention hashtag" rel="nofollow noopener" target="_blank">#genomeediting</a><a href="https://www.asimov.press/p/a-visual-guide-to-genome-editors" rel="nofollow noopener" translate="no" target="_blank">https://www.asimov.press/p/a-visual-guide-to-genome-editors</a>

DasJust mind bogglingly amazing - modern <a href="https://mastodon.online/tags/GeneEditing" class="mention hashtag" rel="nofollow noopener" target="_blank">#GeneEditing</a> therapies! Doesn't get more <a href="https://mastodon.online/tags/PrecisionMedicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#PrecisionMedicine</a> than this!"First Personalized CRISPR Gene Editing Therapy Patient Baby KJ DischargedThree hundred and seven days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), the 10-month-old went home after being treated with a bespoke base editing approach" <a href="https://mastodon.online/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://mastodon.online/tags/CRISPR" class="mention hashtag" rel="nofollow noopener" target="_blank">#CRISPR</a> <a href="https://mastodon.online/tags/genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#genetics</a> <a href="https://www.insideprecisionmedicine.com/topics/precision-medicine/first-personalized-crispr-gene-editing-therapy-patient-baby-kj-discharged/" rel="nofollow noopener" translate="no" target="_blank">https://www.insideprecisionmedicine.com/topics/precision-medicine/first-personalized-crispr-gene-editing-therapy-patient-baby-kj-discharged/</a>

Recent searches

Search options

Administered by:

Server stats:

#crispr